Biopsy arm/elbow soft tissue
CPT code 24066 covers a surgical biopsy of soft tissue in the arm or elbow area, where a doctor removes a tissue sample to test for disease, cancer, or other conditions. This is a more extensive biopsy than a simple needle sample and requires surgical incision.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Always verify place of service code matches actual location - POS 22 (outpatient hospital) triggers facility rate ($423.74) while POS 11 (office) triggers non-facility rate ($616.85)
Impact: Incorrect POS coding results in $193.11 payment difference and potential recoupment
Document depth and complexity of biopsy clearly - superficial biopsies may be downcoded to 11102-11107 series (skin/subcutaneous) which reimburse significantly less
Impact: Proper documentation prevents downcoding from $616.85 to approximately $200-300 for skin biopsy codes
Link appropriate ICD-10 diagnosis codes indicating medical necessity such as D48.1 (neoplasm uncertain behavior soft tissue arm), M79.89 (soft tissue disorder), or R22.31 (localized swelling arm)
Impact: Medical necessity denials account for 30-40% of rejections; proper diagnosis linkage reduces appeal time and improves first-pass payment
When performed with imaging guidance, bill ultrasound guidance (76942) or CT guidance (77012) separately - these are not bundled with 24066
Impact: Additional $150-250 reimbursement for imaging guidance when documented and medically necessary
Ensure pathology interpretation (88305 or higher) is billed separately by pathologist - this is not included in surgical code reimbursement
Impact: Pathology adds $100-400 to total case reimbursement but must be billed by pathology department separately
For Medicare patients, verify biopsy is not being performed within global period of recent arm/elbow surgery unless using appropriate modifier 78 or 79
Global period violations result in 100% denials; proper modifier use recovers 70-100% of payment
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.